Skip to main content

Table 2 Reporting of informed consent and ethical approval in clinical research in leading nursing journals between 2015 and 2017

From: Reporting of ethical approval and informed consent in clinical research published in leading nursing journals: a retrospective observational study

Items

Number of clinical researches

Number of Prospective studies

N (%)

Informed consent reported

Ethical approval reported

Year

 2015

398

364 (91.5)

328 (90.1)

376 (94.5)

 2016

510

477 (93.5)

411 (86.2)

477 (93.5)

 2017

376

344 (91.5)

298 (86.6)

350 (93.1)

X2

  

0.462

0.045

P value

  

0.794

0.978

Study type

 Prospective studies

1185

1037 (87.5)

1121 (94.6)

 Randomized controlled trial

122

113 (92.6)

119 (97.5)

 Nonrandomized trial

62

52 (83.9)

61 (98.4)

 Observational study

835

734 (87.9)

792 (94.9)

 Single-arm

66

52 (78.8)

55 (83.3)

 Specimen

0

0

0

 Mixed methods study

100

86 (86.0)

94 (94.0)

 Retrospective studies

99

82 (82.8)

 Specimen

0

0

 Chart review

21

20 (95.2)

 Database analysis

78

62 (79.5)

P value

  

< 0.001

Mentioning financial support

 Yes

702

662 (94.3)

587 (88.7)

668 (95.2)

 No

582

523 (89.9)

450 (86.0)

535 (91.9)

P value

  

0.185

0.021

The country of conducting the research

 US

186

155 (83.3)

127 (81.9)

175 (94.1)

 Australia

148

137 (92.6)

118 (86.1)

147 (99.3)

 UK

144

136 (94.4)

111 (81.6)

138 (95.8)

 China

124

119 (96.0)

107 (90.0)

118 (95.2)

 Sweden

69

63 (91.3)

59 (93.7)

66 (95.7)

  ≥ 2 countries

63

59 (93.7)

48 (81.4)

52 (82.5)

 Canada

60

55 (91.7)

51 (92.7)

58 (96.7)

 Netherlands

47

44 (93.6)

39 (88.6)

42 (89.4)

 Spain

43

40 (93.0)

35 (87.5)

31 (72.1)

 Korea

43

41 (95.3)

39 (95.1)

43 (100)

 Turkey

33

33 (100)

33 (100)

28 (84.9)

 Norway

25

23 (92.0)

22 (95.7)

24 (96.0)

 Italy

25

23 (92.0)

21 (91.3)

23 (92.0)

 Japan

19

16 (84.2)

15 (93.8)

19 (100)

 Finland

17

16 (94.1)

14 (87.5)

15 (88.2)

 Ireland

17

16 (94.1)

12 (75.0)

13 (76.5)

 Singapore

17

17 (100)

16 (94.1)

16 (94.1)

 Israel

16

12 (75.0)

9 (75.0)

16 (100)

 Germany

15

14 (93.3)

11 (78.6)

13 (86.7)

 Denmark

14

14 (100)

14 (100)

13 (92.9)

 Belgium

13

13 (100)

12 (92.3)

13 (100)

 Iran

13

13 (100)

12 (92.3)

13 (100)

 Jordan

11

11 (100)

10 (90.1)

10 (90.1)

 Brazil

11

10 (90.1)

9 (90.0)

11 (100)

 France

9

7 (77.8)

5 (71.4)

8 (88.9)

 New Zealand

8

6 (75.0)

4 (66.7)

8 (100)

 Switzerland

8

8 (100)

8 (100)

7 (87.5)

 Thailand

7

7 (100)

6 (85.7)

7 (100)

 South Africa

6

6 (100)

6 (100)

6 (100)

 Greece

5

5 (100)

4 (80.0)

5 (100)

 Poland

5

5 (100)

5 (100)

5 (100)

 Portugal

5

5 (100)

5 (100)

5 (100)

 Iceland

4

3 (75.0)

3 (100)

3 (75.0)

 India

4

4 (100)

3 (75.0)

4 (100)

 Indonesia

4

4 (100)

3 (75.0)

4 (100)

 Malaysia

4

4 (100)

4 (100)

4 (100)

 Lebanon

4

4 (100)

4 (100)

4 (100)

 Philippines

4

4 (100)

4 (100)

4 (100)

 Saudi Arabia

4

4 (100)

2 (50.0)

3 (75.0)

 Croatia

3

3 (100)

2 (66.7)

3 (100)

 Afghanistan

2

2 (100)

2 (100)

2 (100)

 Africa

2

2 (100)

2 (100)

2 (100)

 Chile

2

1 (50.0)

1 (100)

2 (100)

 Mexico

2

2 (100)

2 (100)

2 (100)

 Nepal

2

2 (100)

2 (100)

2 (100)

 Oman

2

2 (100)

2 (100)

2 (100)

 Brunei

1

1 (100)

1 (100)

1 (100)

 Dutch

1

1 (100)

1 (100)

1 (100)

 Egypt

1

1 (100)

1 (100)

1 (100)

 Ethiopia

1

1 (100)

1 (100)

1 (100)

 Florida

1

1 (100)

1 (100)

1 (100)

 Lithuania

1

1 (100)

1 (100)

1 (100)

 Madagascar

1

1 (100)

1 (100)

0

 Malawi

1

1 (100)

1 (100)

1 (100)

 Nigeria

1

1 (100)

1 (100)

1 (100)

 Pakistan

1

1 (100)

1 (100)

1 (100)

 Palestine

1

1 (100)

1 (100)

1 (100)

 Qatar

1

1 (100)

1 (100)

1 (100)

 Serbia

1

1 (100)

1 (100)

1 (100)

 Slovenia

1

1 (100)

0

1 (100)

 Srilanka

1

1 (100)

1 (100)

1 (100)

P value

  

< 0.001

< 0.001